z-logo
open-access-imgOpen Access
Crohn�s Disease induced by Ocrelizumab in a patient with multiple sclerosis
Author(s) -
Lorena Carballo-Folgoso,
Miriam Celada-Sendino,
Andrés Castaño-García,
Pedro Oliva Nacarino,
Patricia Morales del Burgo,
Isabel PérezMartínez,
Ruth de Francisco,
Sabino Riestra
Publication year - 2022
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2022.9152/2022
Subject(s) - ocrelizumab , medicine , multiple sclerosis , monoclonal antibody , crohn's disease , disease , inflammatory bowel disease , cd20 , immunology , monoclonal , antibody , rituximab

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here